PD-1 inhibition with retifanlimab and/or arginase inhibition with INCB001158 in Japanese patients with solid tumors: A phase I study.
Kuboki Y, Koyama T, Matsubara N, Naito Y, Kondo S, Harano K, Yonemori K, Yoh K, Gu Y, Mita T, Chen X, Ueda E, Yamamoto N, Doi T, Shimizu T.
Kuboki Y, et al. Among authors: doi t.
Cancer Med. 2024 Apr;13(8):e6980. doi: 10.1002/cam4.6980.
Cancer Med. 2024.
PMID: 38651187
Free PMC article.
Clinical Trial.